One-Liner
A patient-organized petition platform that helps people experiencing suspected drug side effects coordinate, aggregate their reports, and jointly file structured petitions to the FDA or EMA.
AI Thinking Process
FDA 46 novel approvals 2025; post-approval AE reporting famously under-reported. Individual patients have near-zero enforcement power when reporting solo.
Patient posts to Reddit/Facebook, calls pharma 1-800, rarely files MedWatch. Isolated anecdotes, regulators see only pharma-filtered reports.
Verb Transplant: 'class action' from civil litigation → adverse drug event regulatory petition. Not suing pharma but forming a structured regulatory petition cohort — 500-patient cohort with identical structured AE profiles triggers FDA signal.
FDA MedWatch (individual), FDA FAERS (aggregator not patient-facing), RxISK (educational, some self-report), MedShadow Foundation (advocacy). Nobody runs patient-owned petition layer producing regulator-ready filings.
G053 concern: PI firm capture risk. Personal injury firms could fund/capture the cohort, push toward mass-tort plaintiff pipeline, destroy regulator trust.
Mitigation: 501(c)(3)-governed data layer or LLC with nonprofit governance. PI firms pay for access but don't control. Revised conviction 50% after mitigation.
Borderline survived at 50% with founding-choice mitigation explicit.
TEMPLATE GATE: shares structural template 'patient-owned permissioned data layer + inquiring-party-pays' with Thread 8. Thread 8 is stronger (cleaner Pastor pass, no PI-firm capture risk, established advocacy distribution, novel enabling tech). Kill-the-weaker per Pass 2 protocol.
Kill Reason
Structural template overlap with the stronger Thread 8 (patient-owned permissioned data layer, monetized via inquiring-party fees). Thread 9 carries an additional PI-firm capture risk that Thread 8 does not — personal injury law firms could capture the cohort and push it toward mass-tort filing, destroying regulator trust. Thread 8 is the stronger expression of the same core pattern.
Risk Analysis
Risk analysis available for latest engine ideas.
What do you think?
Related ideas you can explore free:
killed: Structural template overlap with the stronger Thread 8 (patient-owned permissioned data layer, monetized via inquiring-party fees). Thread 9 carries an additional PI-firm capture risk that Thread 8 does not — personal injury law firms could capture the cohort and push it toward mass-tort filing, destroying regulator trust. Thread 8 is the stronger expression of the same core pattern.
killed: Open-source middleware (HAMi) already provides heterogeneous AI computing virtualization for free. Proprietary play is squeezed between free open-source and vertically integrated hardware vendor ecosystem.
killed: 5+ funded competitors including Cast AI ($1B valuation), OneChronos (backed by Nobel laureate), Akash Network (decentralized, 80% cheaper), Argentum AI (blockchain-settled). Market is claimed with massive capital.